Agarose Bead Technologies

Founded in 2010 and headquartered in Barcelona, Agarose Bead Technologies is a specialized provider of agarose chromatography resins critical for downstream bioprocessing in therapeutic and diagnostic applications. The company's core business revolves around its proprietary agarose bead platform, offering both off-the-shelf products and a flagship custom resin development service tailored to specific client challenges. ABT targets a diverse market from academia and R&D to large-scale biopharmaceutical manufacturing, positioning itself as a key enabler for efficient purification in the growing biologics and diagnostics sectors. Its operational model spans direct online sales for lab-scale volumes and a consultative, bulk-quote approach for commercial-scale opportunities.

Proprietary agarose bead engineering and functionalization for chromatography resins, including Rapid Run™ high-flow beads, crosslinked beads, and custom ligand coupling for affinity, ion exchange, and size exclusion applications. Also produces magnetic agarose beads.

ABT competes in the chromatography resin market against giants like Cytiva, Thermo Fisher Scientific, Merck KGaA, and Bio-Rad Laboratories. Its competitive differentiation lies in its specialization in agarose, a consultative approach to custom resin development, and agility as a smaller, focused supplier, particularly for clients in the EMEA region and those in the diagnostics space.